#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13512	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2185	615.0	0	.	n	.	0	A69G	SNP	69	69	A	320	320	G	780	G,A,T	710,5,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13512	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2185	615.0	0	.	n	.	0	C1450T	SNP	1450	1450	C	1701	1701	T	747	T,C	676,2	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13512	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2185	615.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1435	1435	C	811	C	740	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24976	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3728	668.0	0	.	n	.	0	T695C	SNP	695	695	T	1207	1207	C	712	C,T	655,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24976	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3728	668.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2483	2483	C	803	C	732	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24976	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3728	668.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2557	2557	A	769	A	731	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24976	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3728	668.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	3109	3109	C	784	C	720	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1994	folP	855	855	100.0	folP.l15.c30.ctg.1	1583	125.4	1	SNP	p	R229S	1	.	.	685	687	AGC	1007	1009	AGC	200;200;196	A;G;C	190;190;186	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5570	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3439	161.3	1	SNP	p	S91F	1	.	.	271	273	TTC	686	688	TTC	158;160;160	T;T;C,T	148;150;145,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5570	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3439	161.3	1	SNP	p	D95G	1	.	.	283	285	GGC	698	700	GGC	168;169;166	G;G;C	155;156;151	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5570	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3439	161.3	1	SNP	p	G95N	0	.	.	283	285	GGC	698	700	GGC	168;169;166	G;G;C	155;156;151	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_U_01459	mtrR.WHO_U_01459	1	1	539	1620	mtrR	633	633	99.84	mtrR.l15.c4.ctg.1	1256	128.3	0	.	p	.	0	D79N	NONSYN	235	237	GAT	506	508	AAT	207;203;206	A;A;T	194;193;193	.	.
mtrR.WHO_U_01459	mtrR.WHO_U_01459	1	1	539	1620	mtrR	633	633	99.84	mtrR.l15.c4.ctg.1	1256	128.3	1	SNP	p	G45D	0	.	.	133	135	GGC	404	406	GGC	179;180;179	G;G;C	168;165;165	mtrR.WHO_U_01459:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	794	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c17.ctg.1	889	88.6	0	.	n	.	0	A197.	DEL	197	197	A	548	548	A	208	A	186	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4938	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2889	170.0	0	.	p	.	0	E91G	NONSYN	271	273	GAG	568	570	GGG	209;210;211	G;G;G	197;199;198	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4938	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2889	170.0	1	SNP	p	D86N	0	.	.	256	258	GAC	553	555	GAC	215;213;211	G;A;C	201;200;202	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4938	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2889	170.0	1	SNP	p	S87R	0	.	.	259	261	AGT	556	558	AGT	212;212;212	A;G;T	199;202;202	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4938	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2889	170.0	1	SNP	p	S87I	0	.	.	259	261	AGT	556	558	AGT	212;212;212	A;G;T	199;202;202	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4938	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2889	170.0	1	SNP	p	S87W	0	.	.	259	261	AGT	556	558	AGT	212;212;212	A;G;T	199;202;202	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4938	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2889	170.0	1	SNP	p	S88P	0	.	.	262	264	TCC	559	561	TCC	213;217;214	T;C;C	202;204;203	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4262	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2628	161.4	0	.	p	.	0	R427H	NONSYN	1279	1281	CGC	1640	1642	CAC	246;250;248	C;A;C	225;229;229	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4262	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2628	161.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1589	1591	GGC	261;262;261	G;G;C	240;239;232	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.44.001	penA.44.001	1	1	27	3768	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2427	154.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1302	1304	GCA	199;196;196	G;C;A	180;179;178	penA.44.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	3768	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2427	154.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1305	1307	ATC	191;192;195	A;T;C	177;178;178	penA.44.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	3768	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2427	154.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1317	1319	GTG	205;206;206	G;T;G,A	184;186;184,1	penA.44.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	3768	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2427	154.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1317	1319	GTG	205;206;206	G;T;G,A	184;186;184,1	penA.44.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	3768	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2427	154.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1821	1823	ACC	214;215;215	A;C;C	196;199;198	penA.44.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	3768	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2427	154.8	1	SNP	p	T502V	0	.	.	1504	1506	ACG	1875	1877	ACG	201;199;197	A,G;C;G	164,2;165;165	penA.44.001:1:1:T502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	3768	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2427	154.8	1	SNP	p	T502P	0	.	.	1504	1506	ACG	1875	1877	ACG	201;199;197	A,G;C;G	164,2;165;165	penA.44.001:1:1:T502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	3768	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2427	154.8	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1998	2000	GGC	204;200;198	G,A;G;C	182,1;177;177	penA.44.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	3768	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2427	154.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2007	2009	GGC	192;193;192	G;G;C,T	172;170;173,1	penA.44.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	3768	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2427	154.8	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2025	2027	CTG	189;194;193	C,G;T,C;G	145,3;150,1;158	penA.44.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5460	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3067	177.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1603	1605	CCG	173;176;175	C;C;G,A	154;162;155,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2282	porA	1146	1146	99.65	porA.l6.c4.ctg.1	1762	128.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	569	569	C	169	C	158	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2476	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1737	142.1	1	SNP	p	G120K	1	.	.	358	360	AAG	678	680	AAG	211;210;209	A;A;G	195;195;192	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2476	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1737	142.1	1	SNP	p	N121D	0	.	.	361	363	AAC	681	683	AAC	210;207;206	A;A;C	194;193;191	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2476	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1737	142.1	1	SNP	p	A121N	1	.	.	361	363	AAC	681	683	AAC	210;207;206	A;A;C	194;193;191	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	9646	rpoB	4179	4179	100.0	rpoB.l15.c17.ctg.1	4777	201.4	1	SNP	p	H553N	0	.	.	1657	1659	CAT	1945	1947	CAT	207;207;211	C;A;T	192;192;195	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1058	rpsJ	312	312	100.0	rpsJ.l6.c30.ctg.1	1041	100.8	1	SNP	p	V57M	1	.	.	169	171	ATG	528	530	ATG	215;213;215	A;T;G	208;204;206	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
